1.A Study on Irrigating Solution in Neurosurgery.
Kang Joon YOON ; Sae Moon OH ; Sun Kil CHOI ; Seoung Koo KANG
Journal of Korean Neurosurgical Society 1988;17(4):631-638
No abstract available.
Neurosurgery*
2.A Study on Irrigating Solution in Neurosurgery.
Kang Joon YOON ; Sae Moon OH ; Sun Kil CHOI ; Seoung Koo KANG
Journal of Korean Neurosurgical Society 1988;17(4):631-638
No abstract available.
Neurosurgery*
3.A Case of Crouzon's Disease.
Moo Shik SOHN ; Won Seek KIM ; Seoung Keun OH ; Seung Koo KANG ; Chong Nham KIM ; In Hee LEE
Journal of the Korean Ophthalmological Society 1970;11(4):83-86
A case of Crouzon's disease, in spite of the relatively small number of cases reported until recently. The patient was 3years old male and hospitalized Woo-Sok University hospital 5 May, 1970. the appearance of the patient was striking type of facial deformity. There is a marked frontal boss forming a prominent bregmatic tumour, hooked nose, a small receding maxilla and a pronounced prognathism in wthich the teeth of the lower jaw protrude several centimetres beyond those of the upper. Proptosis and subnormal mentality was present, Cerebral decompression had been performed to the patient for his exophthalmos, it was aggreviated after the operation and thus enucleation was done finally.
Congenital Abnormalities
;
Craniofacial Dysostosis*
;
Decompression
;
Exophthalmos
;
Humans
;
Jaw
;
Male
;
Maxilla
;
Nose
;
Prognathism
;
Strikes, Employee
;
Tooth
4.The Results of Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
Mi Sook KIM ; Seoung Yul YOO ; Chul Koo CHO ; Jae Young KIM ; Jae Won SHIM ; Choon Taek LEE ; Yoon Koo KANG ; Tae You KIM
Journal of the Korean Society for Therapeutic Radiology 1997;15(3):233-242
PURPOSE: This study was done to evaluate the survival rate and prognostic factors of patients with inoperable non-small cell lung cancer (NSCLC) treated with radiation therapy. MATERIALS AND METHODS: A retrospective analysis was undertaken of 62 patients who had inoperable NSCLC treated with radiation therapy from January 1991 through December 1993. According to AJCC staging, stage III A was 14 patients and stage IIIB was 48 patients. Forty Gy to 70.2Gy to the primary tumor site was delivered with daily fractions of 1.8Gy or 2Gy, 5 days per week. Thirty-seven patients received neoadjuvant chemotherapy. RESULTS: Complete, partial and no response to radiation therapy were 3 patients, 34 patients and 25 patients, respectively. The median survival period of all patients was 11 month. One year survival rate, 2 year survival rate and 5 year survival rate for all patients were 45.0%, 14.3%, and 6.0% respectively. The median survival period was 6.5 months in stage IIIA and 13 months in stage IIIB. One year survival rates were 28.6% in stage IIIA and 50.3% in stage IIIB. In univariaite analysis, prognostic factors affecting survival were T-staging, AJCC staging, and response after radiation therapy (P<0.05). Pretreatment peformance status affected survival but was not statistically significant (0.05
Brain ; Carcinoma, Non-Small-Cell Lung* ; Chemoradiotherapy ; Drug Therapy ; Follow-Up Studies ; Humans ; Liver ; Lung ; Lymph Nodes ; Multivariate Analysis ; Neoplasm Metastasis ; Pathology ; Radiotherapy ; Retrospective Studies ; Survival Rate
5.A Case of Necrotizing Colitis Presenting with Hepatic Portal Venous Gas and Pneumatosis Intestinalis.
Jong Gyu SONG ; Ja Seol KOO ; Hyo Sung KANG ; Jin Yong PARK ; Seoung Young KIM ; Jong Jin HYUN ; Sung Woo JUNG ; Sang Woo LEE
The Korean Journal of Gastroenterology 2015;65(3):177-181
Hepatic portal venous gas is a very rare radiologic sign which is characterized by gas accumulation in the portal venous circulation. Pneumatosis intestinalis is also very rare and is characterized by multiple air cysts in the serosal or submucosal layers of the gastrointestinal tract walls. These two findings are caused by various pathological conditions and can develop individually or simultaneously. The latter is clinically more significant because it is frequently related to bowel ischemia or necrosis, and represents a poor prognosis. However, prognosis is more influenced by the severity of underlying disease rather than hepatic portal venous gas or pneumatosis intestinalis itself. If bowel ischemia or necrosis is the primary cause, emergency operation is very important to improve patient's prognosis. Herein, we report a case of necrotizing colitis presenting as hepatic portal venous gas and pneumatosis intestinalis which was successfully managed by early surgery.
Colitis/complications/*diagnosis/surgery
;
Humans
;
Intestinal Perforation
;
Male
;
Middle Aged
;
Necrosis
;
Pneumatosis Cystoides Intestinalis/complications/*diagnosis
;
Portal Vein
;
Radiography, Abdominal
;
Tomography, X-Ray Computed
6.A Case of Stress-Induced Cardiomyopathy in Sheehan's Syndrome.
Seoung Ho LEE ; Kyu Jin KIM ; Bo Yeon KIM ; Chan Hee JUNG ; Ji Oh MOK ; Sung Koo KANG ; Chul Hee KIM
Korean Journal of Medicine 2014;87(3):347-351
Cardiogenic shock after stress-induced cardiomyopathy is very rare and serious, and a reversible, clinical consequence of untreated adrenal insufficiency that is attributable to Sheehan's syndrome. A 53-year-old female presented with confusion, congestive heart failure, and hypotension. Endocrine testing, prior medical history, and brain MRI confirmed the presence of hypopituitarism and secondary adrenal insufficiency owing to undiagnosed Sheehan's syndrome. After glucocorticoid replacement therapy, her cardiac function recovered completely. Stress-induced cardiomyopathy should be considered as a possible cause of unexplained heart failure in patients with Sheehan's syndrome and adrenal insufficiency.
Adrenal Insufficiency
;
Brain
;
Cardiomyopathies*
;
Female
;
Heart Failure
;
Humans
;
Hypopituitarism*
;
Hypotension
;
Magnetic Resonance Imaging
;
Middle Aged
;
Shock, Cardiogenic
7.A case of adrenal adenoma with concurrent Cushing's syndrome and hyperaldosteronism.
Young Geun HYUN ; Hui Kyung JEON ; Yu Bae AHN ; Hoon Joon PARK ; Joon Wook LEE ; Jang Seoung CHAE ; Sung Koo KANG ; Jeong Soo KIM ; Ki Tae KIM ; Seung Ho HAN
Korean Journal of Medicine 2001;61(3):270-275
Cushing's syndrome is produced by the hypersecretion of adrenal glucocorticoids and is characterized by moon face, central obesity, disappearance of diurnal variation of plasma cortisol and unsuppressibility of plasma cortisol by low-dose dexamethasone. On the other hand, hyperaldosteronism is produced by the hypersecretion of aldosterone and is characterized by hypertension and hypokalemia. We report a rare case of adrenal adenoma with concurrent hypercortisolism and hyperaldosteronism manifestated with hypertension, cushingoid appearance, left adrenal mass with low-normal plasma potassium. Laparoscopic unilateral tumor excision was performed and hypertension disappeared after the operation.
Adenoma*
;
Aldosterone
;
Cushing Syndrome*
;
Dexamethasone
;
Glucocorticoids
;
Hand
;
Hydrocortisone
;
Hyperaldosteronism*
;
Hypertension
;
Hypokalemia
;
Obesity, Abdominal
;
Plasma
;
Potassium
8.The Clinical Outcome of IgA Nephropathy After Renal Transplantation.
Se Haeng CHO ; Yu Seun KIM ; Hyun Joo JEONG ; Seoung Woo LEE ; Bon Kwon KOO ; Shin Wook KANG ; Kyu Hun CHOI ; Ho Yung LEE ; Dae Suk HAN ; Ki Il PARK
Korean Journal of Medicine 1997;52(1):91-97
OBJECTIVES: Primary IgA nephropathy is the most common type of glomerulonephritis, which may progress to end stage renal failure in about 30-35% of the cases. The incidence of recurrence of IgA nephropathy in transplanted kidney is approximately 50-60% but IgA nephropathy which is recurred in graft has relatively benign clinical course so the rate of graft loss due to recurrent IgA nephropathy is about 10%. Overall graft survival rate of IgA nephropathy is higher than other glomerular disorders which cause end stage renal disease according to recent clinical studies. However accurate causative disorders of end stage renal failure had seldom been reported by pathologic examination and accurate graft survival rate and recurrence rate of original disease after renal transplantation couldn't be investigated. We performed analysis of clinical outcome and prognosis for IgA group. METHODS: 1259 cases of kidney transplantation were performed in the Severance hospital between Apr 1979 and Dec.1994. We selected 178 cases of those who got renal biopsy and excluded the cases of cadaveric transplants, hepatitis B antigen carrier, diabetes mellitus and not taking cyclosporine A. 178 cases of those were divided into two groups, IgA and nonIgA group. We performed analysis of 5 year graft and patient survival rate between two groups. The IgA group was divided into two group, recurrent and not-recurrent IgA group. We also performed analysis of recurrence rate and graft survival rate between two groups. RESULTS: 1) 62 cases(35.2M) were IgA group and 116 cases were non-IgA group. 2) Male to female ratio of IgA group was 2.9:1, whose age averaged 35 years old. 3) Among 6 cases of the IgA group, 3 cases lost their graft due to chronic rejection, 2 cases due to recurrence and 1 case due to acute rejection. 4) The 5 year graft survival rate of IgA and nonIgA group were 85%, 90% each without statistical significance(p>0.05). The 5 year patient survival rate of IgA and nonlgA group after renal allograft were 100%, 97% each without statistical significance(p>0.05). 5) 266 cases of posttransplant kidney biopsies were performed and 10 cases were diagnosed as recurrent IgA nephropathy with recurrence rate of 15%. 6) Renal insufficiency was noted in 4 cases of recurrent IgA nephropathy, 2 cases of those were chronic renal failure and the other 2 cases lost their graft. The histologic findings of these cases included mesangial widening and proliferation(4 cases), glomerulosclerosis(2 cases), crescent formation(1 cases). 7) The interval between transplantation and recurrence averaged 41 months. 24hr proteinuria and serum level of creatinine at the time of diagnosis averaged 2.6g and 2.2 mg/dl each. 8) Male to female ratio, age, HLA type and degree of HLA match showed no significant difference between nonrecurrent and recurrent IgA group in graft but 5 year graft survival rate of recurrent IgA group was lower than nonrecurrent group with statistical significance(71% vs 83%, p<0.05). CONCLUSION: Recurrent IgA nephropathy in transplanted kidney might be one of major cause of graft loss with chronic rejection. However precise pathologic examination of before k after transplantation on larger patient population and more long term follow-up are advised.
Adult
;
Allografts
;
Biopsy
;
Cadaver
;
Creatinine
;
Cyclosporine
;
Diabetes Mellitus
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Glomerulonephritis
;
Glomerulonephritis, IGA*
;
Graft Survival
;
Hepatitis B
;
Humans
;
Immunoglobulin A*
;
Incidence
;
Kidney
;
Kidney Failure, Chronic
;
Kidney Transplantation*
;
Male
;
Prognosis
;
Proteinuria
;
Recurrence
;
Renal Insufficiency
;
Survival Rate
;
Transplants
9.Treatment Results of Esophageal Carcinoma Treated by Radiation Therapy.
Mi Sook KIM ; Seoung Yul YOO ; Chul Koo CHO ; Hyung Jun YOO ; Kwang Mo YANG ; Jin Oh KANG ; Young Hoo JI ; Dong Hoon LEE ; Baek Yeol RYOO
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2000;18(3):182-186
PURPOSE: To determine treatment protocol for inoperable esophageal cancer patients, we evaluated survival rate and prognostic factors. MATERIALS AND METHODS: We evaluated esophageal cancer treated by curative or palliative aim in KCCH from 1992 to 1996, retrospectively. Recurrent or underdose case below 40 Gy were excluded. The number of male and female were 35 and 5, respectively. Thirty-eight patients were squamous carcinoma and 2 patients were not biopsy proven. Ten patients were treated with radiation therapy and chemotherapy. Median dose of radiation therapy was 59.4 Gy and the range was 40-60 Gy. RESULTS:The median survival is 6.5 months and 1-year survival rate was 28.3%. Age, location, radiation dose and chemotherapy were not significant prognostic factors. Median survivals of patients with below stage III and over stage IVA were 7.6 and 6.2 months respectively, but it is not significant. CONCLUSION:The survival for esophageal cancer is very poor. For patients with curative aim, chemotherapy must be considered. For patients with palliative aim, short-term external beam radiation therapy and/or brachytherapy must be considered.
Biopsy
;
Brachytherapy
;
Carcinoma, Squamous Cell
;
Clinical Protocols
;
Drug Therapy
;
Esophageal Neoplasms
;
Female
;
Humans
;
Male
;
Retrospective Studies
;
Survival Rate
10.A Case of Cured Diabetes Mellitus after Pheochromocytoma Removal.
Chang Kyun HONG ; Yu Bae AHN ; Sul Hye KIM ; Young Sik WOO ; Seoung Goo LEE ; Seung Hyun KO ; Ho Ki SONG ; Kun Ho YOON ; Moo Il KANG ; Bong Yeon CHA ; Kwang Woo LEE ; Ho Young SON ; Sung Koo KANG
Journal of Korean Society of Endocrinology 2001;16(4-5):502-507
Pheochromocytoma is usually associated with a combination of various clinical manifestations caused by the overproduction of catecholamines. It is frequently accompanied by impaired glucose tolerance operating through 2-and-adrenergic mechanisms. A 41-year-old-woman was admitted to the hospital because of poorly-controlled diabetes mellitus and hypertension. She had suffered intermittent paroxysmal attacks of headache and chest discomfort and had been treated intermittently over a 2 year period for diabetes mellitus and hypertension. At admission, the levels of serum epinephrine, norepinephrine urinary excretion of total metanephrine, and VMA were all abnormally elevated. Adrenal CT showed a well-defined, homogenous mass in the right adrenal region and the tumor was diagnosed as pheochromocytoma. After tumor resection, the increased blood level of catecholamines, the urinary excretion of total metanephrine, and VMA were normalized, as was the hyperglycemia state. Diabetes mellitus of the patient was considered permanently resolved after tumor removal by the result of glucose tolerance in 75g oral glucose tolerance test.
Catecholamines
;
Diabetes Mellitus*
;
Epinephrine
;
Glucose
;
Glucose Intolerance
;
Glucose Tolerance Test
;
Headache
;
Humans
;
Hyperglycemia
;
Hypertension
;
Metanephrine
;
Norepinephrine
;
Pheochromocytoma*
;
Thorax